Synergy between ticarcillin/clavulanic acid and aminoglycosides against Pseudomonas aeruginosa infections in neutropenic mice.
Smith
G M
GM
Beecham Pharmaceuticals Research Division, Brockham Park, Betchworth, Surrey.
Beale
A S
AS
Slocombe
B
B
D000617:Aminoglycosides / Q000627:therapeutic use*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019818:Clavulanic Acid / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004338:Drug Combinations; D051379:Mice; D009503:Neutropenia / Q000188:drug therapy* / Q000382:microbiology*; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000145:classification; D013982:Ticarcillin / Q000627:therapeutic use*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D019818:Clavulanic Acid; D013982:Ticarcillin